XML 51 R42.htm IDEA: XBRL DOCUMENT v3.25.3
Commitments under Research and Collaboration Agreements (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payments         $ 11,100    
Clinical development milestones         14,000    
Regulatory events         80,000    
Commercial sales         150,000    
Milestone payments commercial milestones         12,000    
Extension royalties $ 225            
Accrued extension royalties   $ 200     200   $ 200
Development milestones         32,500    
Annual sales milestone payments         $ 50,000    
Net profits from licensed product sales         50.00%    
Payment of development milestones     $ 3,300        
Accrued amount         $ 3,300   3,300
Accrued liabilities   325     325   325
Research and Development Expense [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payments         70,000    
Royalties amount   6   $ 6 19 $ 19  
MedImmune License Agreement [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payments         244,000    
NCI License Agreement [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payments         3,995    
Royalties amount         25    
MSK License Agreement [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payment upon achieving         10,500    
Milestone payment on net sales         30,000    
Accrued royalties   790     790   790
VAZYME License Agreement [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Milestone payments         200    
Accrued liabilities   $ 200     200   200
Other Accrued Expenses and Accounts Payable [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Patent costs reimbursements         273   273
Other Accrued Expenses [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Patent costs reimbursements         169   $ 169
Minimum [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Royalties amount         20    
Maximum [Member]              
Commitments under Research and Collaboration Agreements [Line Items]              
Royalties amount         $ 30